What are the cutoff levels for Thyroid-Stimulating Hormone (TSH) in pregnancy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

TSH Cutoff Levels in Pregnancy

The recommended TSH cutoff levels for pregnancy are trimester-specific: 0.1-2.5 mIU/L for first trimester, 0.2-3.0 mIU/L for second trimester, and 0.3-3.5 mIU/L for third trimester. 1

Trimester-Specific Reference Ranges

The American College of Reproductive Endocrinologists recommends using trimester-specific reference ranges when evaluating thyroid function during pregnancy:

  • First trimester: 0.1-2.5 mIU/L
  • Second trimester: 0.2-3.0 mIU/L
  • Third trimester: 0.3-3.5 mIU/L 1

These ranges differ from the non-pregnant reference range of 0.45-4.5 mIU/L due to the physiological changes that occur during pregnancy.

Clinical Significance of TSH Levels in Pregnancy

Recent research has demonstrated important clinical implications of maintaining appropriate TSH levels during pregnancy:

  • Women with TSH levels between 2.5-5.0 mIU/L in the first trimester (even within the traditional "normal" non-pregnant range) have a significantly higher risk of pregnancy loss compared to those with TSH below 2.5 mIU/L (6.1% vs 3.6%) 2

  • This provides strong physiological evidence supporting the lower TSH upper limit of 2.5 mIU/L in the first trimester 2

First Trimester Considerations

It's important to note that first trimester TSH values may vary according to gestational week:

  • Up to the sixth week of pregnancy, TSH levels typically remain in the non-pregnant reference range
  • During weeks 9-12, TSH levels are approximately 0.4 mIU/L lower than non-pregnancy upper limits 3

This variation is primarily due to the thyrotropic effects of human chorionic gonadotropin (hCG), which peaks during the first trimester and has TSH-like effects on the thyroid gland.

Monitoring and Management

For pregnant women with pre-existing hypothyroidism on levothyroxine therapy:

  • Up to 75% require higher doses of levothyroxine during pregnancy to maintain normal TSH levels 4
  • TSH should be monitored at least once each trimester 4
  • Increased TSH levels can appear as early as 4-8 weeks of gestation or as late as the third trimester 4
  • After pregnancy, levothyroxine dose should be reduced to the preconception level, with reassessment at 6-12 weeks postpartum 4

Important Clinical Considerations

  • Overtreatment risk: TSH levels below 0.10 mIU/L during pregnancy are associated with increased odds of preterm delivery (adjusted odds ratio: 2.14) 5

  • Monitoring gaps: Studies show that approximately 17.8% of women on thyroid replacement before conception do not have TSH measured during pregnancy, highlighting an important clinical care gap 5

  • TSH limitations: Some research suggests that TSH alone may not be an adequate screening tool for thyroid dysfunction in pregnancy, as abnormal TSH levels don't always correlate with abnormal thyroid hormone levels 6

For optimal management of thyroid function during pregnancy, clinicians should aim to maintain TSH within the trimester-specific reference ranges while avoiding overtreatment, and consider measuring free T4 along with TSH for a more complete assessment of thyroid function.

References

Guideline

Thyroid Dysfunction Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Management of thyroxine therapy during pregnancy.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 1996

Research

Is TSH a Reliable Indicator of Thyroid Hormone Status in Pregnancy?

Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 2022

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.